Price $29.77 |
Market Cap
1.63B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.64
|
P/S
5.39
|
Dividend %
-
|
|
P/CF
46.7
|
P/FCF
76.6
|
Op. Cash Flow
31.3K
|
FCF
0.3
|
|
Op. Margin
-10.20%
|
Net Margin
-8.80%
|
ROE
-2.70%
|
ROI
-3.80%
|
|
ROA
-2.50%
|
EPS Growth
41.30%
|
Current Ratio
4.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
